DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/xcwr9z/global_vaccine) has announced the addition of the "Global Vaccine Market Outlook 2020" report to their offering.
The market, which stood at US$ 30.5 Billion in 2013, is expected to grow at a CAGR of around 12% during 2013-2020.
The pharmaceutical segment has faced diminishing prospects because of declining research and development productivity, stringent regulatory activities and generic competition for off patent products. On the contrary, vaccine segment has developed as highly profitable because of advancements in genomics and manufacturing technologies as well as increasing demand from emerging economies.
Meanwhile, continuous efforts have been put in by the biopharmaceutical companies to create tremendous opportunities for leading players to tap this market. Besides, vaccines have high entry barrier for generic players and potential to generate blockbuster sales, which thereby allure the market players.
This report has segmented the global vaccine market based on 16 therapeutic categories, and market for each has been forecasted. For each therapeutic segment, marketed product portfolio, pipeline products along with recent developments have been analyzed. Followed by this, important geographies have been highlighted along with their current and future markets outlook till 2020.
The report also covers advanced stage pipeline analysis of key players, which list down the vaccines already in Phase III trials. Through this, our analysts have conducted a thorough opportunity assessment in various therapeutic categories and regions to clearly highlight avenues which offer maximum opportunities for growth.
Market Segments
- Pneumococcal
- Influenza
- Cancer
- Polio
- Varicella
- Rotavirus
- Meningococcal
- DTP
- Hepatitis
- Measles, Mumps, and Rubella (MMR)
- Japanese Encephalitis
- Tuberculosis
- Malaria
- Rabies
- Typhoid
- HIV
Key Topics Covered:
1. Analyst View
2. Research Methodology
3. Global Vaccine Market Outlook to 2020
4. Major Vaccines: Current and Future Market Analysis
5. Key Geographical Markets
6. Pipeline Analysis
7. Competitive Landscape
- AstraZeneca Plc.
- Baxter International Inc.
- BioCSL (CSL Biotherapies)
- Crucell
- Dendreon Corporation
- Emergent Biosolutions
- GSK
- Merck
- Novartis
- Pfizer
- Sanofi-Pasteur
- Takeda Pharmaceutical Company Limited
For more information visit http://www.researchandmarkets.com/research/xcwr9z/global_vaccine
